Search

everythinglearnresearchcommunity

for

Search:↓

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Men with androgenetic alopecia may have higher cardiovascular risk due to elevated serum endocan levels.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Thiol/disulfide balance is normal in male AGA patients but shifts towards oxidative stress with emotional stress and low vitamin D.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

5-ARI therapy may help prevent prostate cancer progression.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Finasteride safely lowers DHT levels without affecting testosterone.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.